Dyne Therapeutics, Inc. DYN
Set alert
17.71 USD +0.41 +2.37%
As of Nov 3, 12:24 PM ET
17.32 Day range 18.15
14.25 52-week range 26.78
- YTD
- -9.46%
- 1 year
- -26.55%
- Open
- 17.53
- Prev close
- 17.30
- Mkt cap
- 3.31B
- Vol
- 798.74K
- Avg vol
- 2.78M
- EPS
- -3.30
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.32
- High
- 18.15
- Forward P/E
- -5.22
- Beta
- 1.21
- Short ratio
- 7.94
- Inst. own
- 103.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 18.53
- 200-d avg
- 19.31
- 1y target
- 34.33
5m chart
Built from the cached five-day intraday bars.
Events in this range
- Oct 28, 2026Downgrade: Oppenheimer · Outperform → Perform
Signals (89)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 3:40 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 3:30 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 23 hours ago |
| MACD: Sell Signal | Nov 2, 12:45 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 12:00 PM | 1 day ago |
| SMA: Bullish | Nov 2, 11:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:55 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:30 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 10:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:15 AM | 1 day ago |
| RSI: Overbought | Nov 2, 10:10 AM | 1 day ago |
Newest 20 of 89.
Financial health
Altman Z-Score
3.85 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -5.6×
FY 2016 5y median -4.1× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 2.6×
FY 2016 5y median 2.6× FY 2025
P/FCF -6.2×
FY 2016 5y median -4.9× FY 2025
EV/EBITDA -3.7×
FY 2016 5y median -3.0× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -16.1%
FY 2016 5y median -20.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -45.9%
FY 2016 5y median -50.4% FY 2025
ROIC -41.0%
FY 2016 5y median -52.6% FY 2025
ROA -37.6%
FY 2016 5y median -45.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -36.1%
FY 2016 FY 2025
EPS (diluted) -3.0%
FY 2016 FY 2025
Free Cash Flow -37.4%
FY 2016 FY 2025
Financial Health
Current Ratio 22.3×
FY 2016 5y median 13.3× FY 2025
Quick Ratio 22.3×
FY 2016 5y median 13.3× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 2.0×
FY 2016 5y median 1.1× FY 2025
Interest Coverage -75.6×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
